Download Zipped Amended WordPerfect SB0248.ZIP
[Introduced][Status][Bill Documents][Fiscal Note][Bills Directory]

S.B. 248


Text Box

House Floor Amendments 3-10-2011 le/rf

- 1 -
Senate Committee Amendments 2-24-2011 rd/rf
This document includes Senate Committee Amendments incorporated into the bill on Thu, Feb 24, 2011 at 3:17 PM by rday. --> This document includes House Floor Amendments incorporated into the bill on Thu, Mar 10, 2011 at 4:50 PM by lerror. -->              1
    
CONTROLLED SUBSTANCE DATABASE AMENDMENTS

             2     
2011 GENERAL SESSION

             3     
STATE OF UTAH

             4     
Chief Sponsor: Curtis S. Bramble

             5     
House Sponsor: Bradley M. Daw

             6     

             7      LONG TITLE
             8      General Description:
             9      This bill modifies provisions relating to access to the Controlled Substance Database H. .
             10      [ and requires a physician to review the database before writing a first prescription to a
             11      patient for a schedule II or schedule III controlled substance.
] .H

             12      Highlighted Provisions:
             13          This bill:
             14          .    authorizes certain individuals to access the controlled substance database for the
             15      purpose of reviewing a patient's request for workers' compensation benefits;
             16      H. [     .    requires that a physician review the controlled substance database before writing a
             17      first prescription for a schedule II or schedule III controlled substance to check for
             18      prescription duplication, drug over-use, or drug abuse; and
] .H

             19          .    makes technical changes.
             20      Money Appropriated in this Bill:
             21          None
             22      Other Special Clauses:
             23           S. [ None ] This bill takes effect on January 1, 2012. .S
             24      Utah Code Sections Affected:
             25      AMENDS:
             26          58-37f-301, as enacted by Laws of Utah 2010, Chapter 287 and last amended by
             27      Coordination Clause, Laws of Utah 2010, Chapter 312



Text Box

- 2 -
             28
     ENACTS:
             29          58-37f-704, Utah Code Annotated 1953
             30     

             31      Be it enacted by the Legislature of the state of Utah:
             32          Section 1. Section 58-37f-301 is amended to read:
             33           58-37f-301. Access to database.
             34          (1) The division shall make rules, in accordance with Title 63G, Chapter 3, Utah
             35      Administrative Rulemaking Act, to:
             36          (a) effectively enforce the limitations on access to the database as described in this
             37      part; and
             38          (b) establish standards and procedures to ensure accurate identification of individuals
             39      requesting information or receiving information without request from the database.
             40          (2) The division shall make information in the database available only to the following
             41      individuals, in accordance with the requirements of this chapter and division rules:
             42          (a) personnel of the division specifically assigned to conduct investigations related to
             43      controlled substance laws under the jurisdiction of the division;
             44          (b) authorized division personnel engaged in analysis of controlled substance
             45      prescription information as a part of the assigned duties and responsibilities of their
             46      employment;
             47          (c) in accordance with a written agreement entered into with the department,
             48      employees of the Department of Health:
             49          (i) whom the director of the Department of Health assigns to conduct scientific studies
             50      regarding the use or abuse of controlled substances, provided that the identity of the individuals
             51      and pharmacies in the database are confidential and are not disclosed in any manner to any
             52      individual who is not directly involved in the scientific studies; or
             53          (ii) when the information is requested by the Department of Health in relation to a
             54      person whom the Department of Health suspects may be improperly obtaining or providing a
             55      controlled substance;
             56          (d) a licensed practitioner having authority to prescribe controlled substances, to the
             57      extent the information:
             58          (i) (A) relates specifically to a current or prospective patient of the practitioner; and



Text Box

- 3 -
             59
         (B) is sought by the practitioner for the purpose of:
             60          (I) prescribing or considering prescribing any controlled substance to the current or
             61      prospective patient;
             62          (II) diagnosing the current or prospective patient;
             63          (III) providing medical treatment or medical advice to the current or prospective
             64      patient; or
             65          (IV) determining whether the current or prospective patient:
             66          (Aa) is attempting to fraudulently obtain a controlled substance from the practitioner;
             67      or
             68          (Bb) has fraudulently obtained, or attempted to fraudulently obtain, a controlled
             69      substance from the practitioner;
             70          (ii) (A) relates specifically to a former patient of the practitioner; and
             71          (B) is sought by the practitioner for the purpose of determining whether the former
             72      patient has fraudulently obtained, or has attempted to fraudulently obtain, a controlled
             73      substance from the practitioner;
             74          (iii) relates specifically to an individual who has access to the practitioner's Drug
             75      Enforcement Administration identification number, and the practitioner suspects that the
             76      individual may have used the practitioner's Drug Enforcement Administration identification
             77      number to fraudulently acquire or prescribe a controlled substance;
             78          (iv) relates to the practitioner's own prescribing practices, except when specifically
             79      prohibited by the division by administrative rule;
             80          (v) relates to the use of the controlled substance database by an employee of the
             81      practitioner, described in Subsection (2)(e); or
             82          (vi) relates to any use of the practitioner's Drug Enforcement Administration
             83      identification number to obtain, attempt to obtain, prescribe, or attempt to prescribe, a
             84      controlled substance;
             85          (e) in accordance with Subsection (3)(a), an employee of a practitioner described in
             86      Subsection (2)(d), for a purpose described in Subsection (2)(d)(i) or (ii), if:
             87          (i) the employee is designated by the practitioner as an individual authorized to access
             88      the information on behalf of the practitioner;
             89          (ii) the practitioner provides written notice to the division of the identity of the



Text Box

- 4 -
             90
     employee; and
             91          (iii) the division:
             92          (A) grants the employee access to the database; and
             93          (B) provides the employee with a password that is unique to that employee to access
             94      the database in order to permit the division to comply with the requirements of Subsection
             95      58-37f-203 (3)(b) with respect to the employee;
             96          (f) a licensed pharmacist having authority to dispense a controlled substance to the
             97      extent the information is sought for the purpose of:
             98          (i) dispensing or considering dispensing any controlled substance; or
             99          (ii) determining whether a person:
             100          (A) is attempting to fraudulently obtain a controlled substance from the pharmacist; or
             101          (B) has fraudulently obtained, or attempted to fraudulently obtain, a controlled
             102      substance from the pharmacist;
             103          (g) federal, state, and local law enforcement authorities, and state and local
             104      prosecutors, engaged as a specified duty of their employment in enforcing laws:
             105          (i) regulating controlled substances; or
             106          (ii) investigating insurance fraud, Medicaid fraud, or Medicare fraud;
             107          (h) a mental health therapist, if:
             108          (i) the information relates to a patient who is:
             109          (A) enrolled in a licensed substance abuse treatment program; and
             110          (B) receiving treatment from, or under the direction of, the mental health therapist as
             111      part of the patient's participation in the licensed substance abuse treatment program described
             112      in Subsection (2)(h)(i)(A);
             113          (ii) the information is sought for the purpose of determining whether the patient is
             114      using a controlled substance while the patient is enrolled in the licensed substance abuse
             115      treatment program described in Subsection (2)(h)(i)(A); and
             116          (iii) the licensed substance abuse treatment program described in Subsection
             117      (2)(h)(i)(A) is associated with a practitioner who:
             118          (A) is a physician, a physician assistant, an advance practice registered nurse, or a
             119      pharmacist; and
             120          (B) is available to consult with the mental health therapist regarding the information



Text Box

- 5 -
Senate Committee Amendments 2-24-2011 rd/rf
             121
     obtained by the mental health therapist, under this Subsection (2)(h), from the database; [and]
             122          (i) an individual who is the recipient of a controlled substance prescription entered into
             123      the database, upon providing evidence satisfactory to the division that the individual requesting
             124      the information is in fact the individual about whom the data entry was made[.];
             125          (j) the following licensed physicians for the purpose of reviewing and offering an
             126      opinion on an individual's request for workers' compensation benefits under Title 34A, Chapter
             127      2, Workers' Compensation Act, or Title 34A, Chapter 3, Utah Occupational Disease Act:
             128          (i) a member of the medical panel described in Section 34A-2-601 ; S. or
             129           [ (ii) the medical director for the Labor Commission;
             130          (iii) the medical director for a workers' compensation insurer; or
             131          (iv) the medical director for a self-insured employer; and

             131a          (ii) a physician offering a second opinion regarding treatment.
             132          (k) a physician for the purpose of checking for prescription duplication, drug over-use,
             133      or drug abuse pursuant to Section 58-37f-704 .
] .S

             134          (3) (a) A practitioner described in Subsection (2)(d) may designate up to three
             135      employees to access information from the database under Subsection (2)(e).
             136          (b) The division shall make rules, in accordance with Title 63G, Chapter 3, Utah
             137      Administrative Rulemaking Act, to establish background check procedures to determine
             138      whether an employee designated under Subsection (2)(e)(i) should be granted access to the
             139      database.
             140          (c) The division shall grant an employee designated under Subsection (2)(e)(i) access
             141      to the database, unless the division determines, based on a background check, that the
             142      employee poses a security risk to the information contained in the database.
             143          (d) The division may impose a fee, in accordance with Section 63J-1-504 , on a
             144      practitioner who designates an employee under Subsection (2)(e)(i), to pay for the costs
             145      incurred by the division to conduct the background check and make the determination
             146      described in Subsection (3)(b).
             147          (4) (a) An individual who is granted access to the database based on the fact that the
             148      individual is a licensed practitioner or a mental health therapist shall be denied access to the
             149      database when the individual is no longer licensed.
             150          (b) An individual who is granted access to the database based on the fact that the
             151      individual is a designated employee of a licensed practitioner shall be denied access to the



Text Box

- 6 -
Senate Committee Amendments 2-24-2011 rd/rf
             152
     database when the practitioner is no longer licensed.
             153           S. [ Section 2. Section 58-37f-704 is enacted to read:
             154          58-37f-704. Requirement to check controlled substance database.
             155          A licensed physician shall review the database before writing a first prescription to a
             156      patient for a schedule II or schedule III controlled substance to determine if there is evidence
             157      relating to the patient of:
             158          (1) prescription duplication;
             159          (2) drug over-use; or
             160          (3) drug abuse.
] Section 2. Effective Date
             160a      This bill takes effect on January 1, 2012. .S





Legislative Review Note
    as of 2-15-11 10:49 AM


Office of Legislative Research and General Counsel


[Bill Documents][Bills Directory]